Pathways regulating fear in the nucleus accumbens - PROJECT SUMMARY/ABSTRACT
Excessive associative fear is a hallmark symptom of many anxiety disorders and phobias. These disorders
frequently co-occur with substance abuse or mood dysregulation, severely complicating treatment and the
recovery process. The nucleus accumbens (NAc), critically involved in reward and substance abuse, is also
implicated in aversive processing (ie., fear). Yet how the NAc is regulated by the amygdala and the infralimbic
cortex (IL), two critical regions implicated in controlling fear responses, is not clear. Robust glutamatergic axons
from the basolateral amygdala (BLA) and the IL innervate both shell and core NAc subregions. To evaluate how
fear responses are modulated by these glutamatergic inputs into the NAc, we use an associative fear
conditioning paradigm in mice. This involves having mice associate a previously neutral conditioned stimulus
(CS; auditory tone) with an unconditioned stimulus (US; mild foot shock) that produces a threat response,
quantified by measuring the natural freezing of mice (higher freezing indicates more fear). This associative fear
response is reduced by repeated CS-alone presentations, a process called extinction that has major implications
for exposure therapy in humans. We have previously shown that optogenetic activation of specific glutamatergic
BLA neurons promoted the consolidation of extinction without affecting fear expression. Our pilot data here
demonstrate that optogenetic stimulation of BLA terminals in the NAc enhances the consolidation of fear
extinction. In addition, we show that inhibiting group I metabotropic glutamate receptors (mGluRs) significantly
impairs the consolidation of extinction but has no effect on fear expression. Blocking AMPA receptors, however,
reduces fear expression without altering extinction learning. The BLA and IL are critical nodes involved in fear
acquisition, expression, and extinction. The NAc is a target of BLA and IL axon terminals and both circuits are
important for modulating aversive behaviors. To evaluate if BLA-NAc and IL-NAc glutamatergic projections
modulate fear expression and extinction learning, we propose to optogenetically activate or inhibit BLA or IL
neurons that project specifically to the NAc during fear testing or extinction (Aim 1). In Aim 2 we will
pharmacologically evaluate the roles that AMPA receptors and mGluR1 in the NAc play in fear expression and
extinction learning. Next, we will extend characterization of this circuit by further determining which glutamate
receptors are responsible for BLA or IL driven fear responses. These novel experiments will improve
understanding of the circuitry involved in associative fear processing within the NAc. Because this brain region
is also implicated in mood and substance abuse disorders, these experiments will contribute a critical framework
for investigations into the mechanisms of co-morbidity.